|
|
Simcere’s Q1: Revenue Increases 26%; Net Up 68%
publication date: May 6, 2008
Simcere Pharmaceutical Group released its first quarter financial report showing modestly higher revenues and a large increase in net profit. In Q1, Simcere booked revenues of 394 million RMB ($56.3 million), a solid increase of 26% from the year earlier period, and net income of 112 million RMB ($16 million), a much larger jump of 68%. The increases came from the company's three first-to-market products. More details...
Stock Symbol: (NYSE: SCR)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|